Dry Eye (KCS) in Maltese: Prevention and Treatment Tips

Category: chronic_disease Breed: Maltese (dog) — Senior: 8–9 years (typical lifespan 12–15 years)

Keratoconjunctivitis sicca (KCS), commonly called "dry eye," is an inflammatory disease of the ocular surface caused by inadequate tear production or poor tear-film quality. In senior Maltese dogs (8–9 years and older), KCS is an important and treatable cause of chronic eye irritation, corneal damage, and vision loss if left untreated. This breed-specific guide explains how KCS presents in older Maltese, how it is diagnosed and treated, and what practical steps owners can take at home — especially when the Maltese also has common comorbidities such as [mitral valve disease](https://seniorpet.org/knowledge/cavalier-king-charles-spaniel-mitral-valve-disease "Mitral Valve Disease Guide") (MVD), cataracts, [dental disease](https://seniorpet.org/knowledge/siamese-cat-dental-disease "Dental Disease in Senior Pets"), collapsed trachea, luxating patella, portosystemic shunt, or white shaker syndrome.

Why Maltese are a special case

Maltese are a toy breed with large, prominent eyes relative to their skull size, often with shallow orbits and long facial hair. These features create several breed-specific risk factors for KCS and its complications:

• Prominent eyes and shallow orbits increase exposure and evaporation of tears, worsening dry-eye symptoms.
• Long facial and periocular hair can rub the cornea and destabilize the tear film, increasing irritation and risk of secondary corneal ulcers.
• Small-breed seniors commonly have concurrent conditions (dental disease, MVD, cataracts) and receive systemic medications (e.g., sulfonamides for infections, corticosteroids for immune disease) that can affect tear production or corneal healing.
• As Maltese age into the senior range (8–9 years), baseline tear production may decline and immune-mediated causes become more common.

Recognizing and treating KCS promptly in a Maltese is key to preserving comfort and vision.

How KCS develops in Maltese

Mechanisms include:

• Immune-mediated destruction of lacrimal glands (most common cause in dogs).
• Drug-induced reduction (sulfonamides are a classic cause).
• Neurogenic KCS from damage to the facial or trigeminal nerves.
• Age-related decline in lacrimal and meibomian gland function.
• Secondary tear-film instability from eyelid and facial-hair conformation.

Because Maltese are often groomed close to the eyes, mechanical irritation and topical product exposure can also play a role.

Typical clinical signs in a senior Maltese

• Thick, mucoid or mucopurulent ocular discharge (more than watery).
• Chronic redness and eyelid inflammation.
• Frequent pawing at or rubbing of eyes.
• Dull, cloudy, or pigmented cornea (early scarring).
• Recurrent corneal ulcers (may be resistant to healing).
• Decreased blinking and squinting (blepharospasm).
• Secondary conjunctivitis or eyelid crusting.

Owners may initially think this is "allergy" or normal tearing; the discharged material in KCS is often ropey rather than watery.

Diagnosis — what the veterinarian will do

A thorough ophthalmic exam by your veterinarian (or ideally a veterinary ophthalmologist) should include:

• Schirmer Tear Test (STT): gold-standard for measuring aqueous tear production. Normal dogs: roughly 15–25 mm/min. Mild KCS: 10–15 mm/min; moderate-to-severe: <10 mm/min. (See table below.)
• Fluorescein stain: to detect corneal ulcers.
• Tear-film breakup time (TBUT) or evaluation of mucin layer if available.
• Cytology and culture if secondary infection is suspected.
• Assessment of eyelid conformation, facial hair, and blink completeness.
• Neurologic exam if neurogenic causes are suspected.
• Review of medications and medical history (sulfonamides, prior surgery, systemic immune disease, steroid or azathioprine use).

Table: STT interpretation and recommended actions

| STT (mm/min) | Interpretation | Recommended immediate action | |---:|---|---| | >15 | Normal | Routine monitoring; consider tear supplements only if clinical signs present | | 10–15 | Borderline / mild KCS | Begin tear supplements; repeat STT in 2–4 weeks; consider topical cyclosporine if clinical signs persist | | <10 | Moderate to severe KCS | Start topical lacrimomimetic therapy (cyclosporine or tacrolimus) + tear supplements; check for corneal ulcers and start topical antibiotics if infected | | 0–5 | Marked deficiency | Aggressive medical therapy, frequent lubrication, consider surgical options (e.g., parotid duct transposition) if refractory |

(Note: STT interpretation can vary by lab and patient. Treatment decisions should be individualized.)

Medical treatment options (what works best in Maltese)

The primary goal is to increase tear production and protect the corneal surface while treating or preventing secondary infection.

Tear stimulants (first-line)

- Topical cyclosporine ophthalmic (0.2% ophthalmic ointment; Optimmune®) — typically one application twice daily. Cyclosporine is an immunomodulator that restores lacrimal gland function in many immune-mediated cases and also reduces conjunctival inflammation (Veterinary Ophthalmology reviews report consistent improvement in STT values and clinical signs). - Tacrolimus ophthalmic (0.03%–0.1%, compounded) — increasingly used and can be more potent than cyclosporine in some refractory cases; 1 drop twice daily is a common regimen (use preservative-free formulations). - Important: owners should expect weeks to months for full improvement; many dogs require lifelong topical therapy.

Tear replacements and mucinomimetics

- Preservative-free artificial tears (carboxymethylcellulose, hyaluronic acid) given several times daily and gels/ointments at bedtime to maintain ocular surface hydration. - Hyaluronate (0.1%–0.4%) eye drops are particularly helpful for tear-film stability. - Use liberal lubrication during grooming or when air movement is strong.

Antibiotics for secondary infection

- Topical broad-spectrum antibiotics (e.g., ofloxacin, ciprofloxacin ophthalmic solutions) are used if ulceration or bacterial overgrowth is present. Avoid topical corticosteroids if corneal ulceration is suspected.

Pilocarpine (for neurogenic KCS)

- Pilocarpine may be effective for neurogenic KCS but has cholinergic side effects; use only under close veterinary guidance.

Systemic medications

- Systemic immunosuppressants are not typically first-line for primary KCS but may be needed for associated immune-mediated disease. Discuss risks with your vet.

Surgery (for refractory or end-stage cases)

- Parotid duct transposition (salivary gland duct transposition) or permanent partial tarsorrhaphy are options if medical therapy fails. Surgery carries anesthetic risk for seniors with MVD or portosystemic shunts; careful pre-op workup and a veterinary ophthalmologist consultation are essential.

Medications and dosing — practical notes for Maltese owners

• Cyclosporine 0.2% ophthalmic ointment: typically 1 application each eye twice daily. If ointment causes blurred vision or irritation, a drop formulation may be preferred.
• Tacrolimus 0.03% ophthalmic solution (compounded preservative-free): 1 drop each eye twice daily.
• Artificial tears (preservative-free): 1–4 times daily or more as needed; gels at bedtime.
• If an antibiotic is prescribed: instill as directed (often q6–8h) until culture negative and clinical healing.

Always use preservative-free formulations in chronic therapy to reduce ocular surface toxicity. If compounding is needed (common in small breeds), use a reputable veterinary compounding pharmacy.

How comorbidities change management in the Maltese senior

When managing KCS in an older Maltese, the common comorbidities you listed require specific considerations:

• Mitral Valve Disease (MVD)

- Many older Maltese have MVD and may be on cardiac medications. Anesthetic risk for ocular surgery is higher; consult with your primary veterinarian and, if possible, a cardiologist before surgical interventions like parotid duct transposition. - Some cardiac drugs (diuretics) can contribute to dehydration; ensure adequate hydration to support tear production.

• Cataracts

- Cataracts often coincide with corneal disease. Corneal scarring from untreated KCS can complicate cataract surgery or visual outcomes. Control dry eye before any elective ocular surgery.

• Luxating patella

- This orthopedic issue usually does not impact ocular therapy directly, but systemic pain medications (e.g., NSAIDs) should be discussed with your vet to ensure no contraindicated drugs are used.

• Portosystemic liver shunt

- Liver disease affects drug metabolism. Some ocular medications are metabolized systemically (e.g., small systemic absorption of cyclosporine or pilocarpine); dose adjustments and drug choice should be assessed by your veterinarian.

• Dental disease

- Chronic dental infection increases systemic inflammation and may worsen immune-mediated conditions. Address dental disease (professional cleaning, extractions as needed) under safe anesthesia protocols to improve overall health and potentially reduce inflammatory load that could affect ocular immune function.

• Collapsed trachea

- Difficulty with intubation and anesthesia planning is a concern for surgical options. Regional or local anesthesia is sometimes used for conjunctival procedures, but surgical decisions must weigh respiratory risk.

• White Shaker Syndrome

- White shaker syndrome is treated with corticosteroids or other immunosuppressive drugs. Systemic steroids can, in some cases, mask immune-mediated KCS or increase risk for corneal infection and ulcers. If a Maltese is receiving systemic steroids, close ophthalmic monitoring is required; steroid use may complicate corneal healing.

Overall: coordinate with your primary vet and specialists (cardiology, internal medicine, ophthalmology) for individualized care plans.

Practical, actionable advice for owners

• Have a baseline STT performed once your Maltese reaches senior status (around 8 years) or earlier if you notice ocular discharge or irritation.
• If your Maltese has chronic mucoid discharge, do not assume "tear stains" only — schedule an ophthalmic exam.
• Be proactive with grooming: trim periocular hair to prevent hair rubbing. Always use scissors carefully or have a professional groomer experienced with small breeds.
• Use preservative-free artificial tears liberally during the day; apply ointment at night.
• Administer topical immunomodulators (cyclosporine or tacrolimus) exactly as prescribed. Missing doses reduces effectiveness and delays recovery.
• Avoid sulfonamide antibiotics unless absolutely necessary; if used, monitor STT during and after treatment.
• Maintain excellent dental care (daily brushing, professional cleanings) to lower systemic inflammation.
• If your Maltese is on multiple systemic medications for MVD or other disease, review all medicines with your veterinarian to identify any that can reduce tear production.
• Keep a photo log of your dog’s eyes (weekly) to detect subtle changes. Bring photos to the vet if a flare occurs between visits.
• Travel-ready tip: bring medications in a labeled, temperature-stable container and carry a copy of the prescription in case your Maltese needs emergency care while away.

Monitoring and follow-up schedule

• Initiation phase: recheck eyes and STT every 4–6 weeks until improvement is stable.
• Maintenance: once stable, monitor every 3–6 months; check STT at least every 6–12 months.
• Immediate recheck if you notice increased redness, pain (squinting), cloudiness, or sudden vision changes — these could indicate ulcers or infection.

Prognosis

With timely, appropriate therapy, many Maltese with immune-mediated KCS respond well to topical cyclosporine or tacrolimus and maintain comfortable, functional vision. Without treatment, KCS can progress to chronic corneal scarring, pigmentation, and blindness. Some dogs will require lifelong topical therapy; refractory cases may require surgical salivary gland transposition or partial tarsorrhaphy.

When to see a specialist

• STT <10 mm/min with ongoing signs despite initial therapy.
• Recurrent or non-healing corneal ulcers.
• Need for surgical options.
• Complex medical history (MVD, portosystemic shunt, respiratory disease) where anesthesia risk is higher — consult both ophthalmology and relevant internal medicine specialists.

Safety notes and owner cautions

• Never use topical corticosteroids unless a veterinarian has ruled out corneal ulceration.
• Avoid over-the-counter eye drops intended for humans unless advised by your vet—many contain preservatives or vasoconstrictors harmful to dogs.
• Compounded products should come from a reputable pharmacy; check for sterile, preservative-free formulations.

Evidence and further reading

• Contemporary reviews in Veterinary Ophthalmology discuss long-term improvement in STT and ocular comfort with topical cyclosporine and tacrolimus in canine KCS.
• Clinical practice guidelines recommend STT as the gold standard diagnostic test and support early use of immunomodulatory therapy to restore lacrimal function and prevent corneal damage (see Veterinary Ophthalmology review articles and JAVMA clinical reports).
• For surgical techniques such as parotid duct transposition, consult surgical case series in veterinary ophthalmology journals for outcomes and anesthetic considerations.

(Ask your veterinarian for references specific to your dog; a board-certified veterinary ophthalmologist can provide citations tailored to your dog’s condition.)

Bottom line

Dry eye is a treatable condition in senior Maltese, but breed traits (prominent eyes, periocular hair) and common comorbidities (MVD, dental disease, collapsed trachea, white shaker syndrome) complicate management. Early diagnosis with an STT, consistent use of topical immunomodulators (cyclosporine or tacrolimus), regular lubrication, and coordination with your veterinarian for medical and surgical decisions will give your Maltese the best chance of comfort and preserved vision as they age.

If you notice persistent mucoid discharge, redness, squinting, or changes in corneal appearance, schedule an ophthalmic exam promptly — these signs are not “just old age.”

---

References and resources (for owners and vets)

• Veterinary Ophthalmology (journal) — review articles on KCS treatment strategies.
• Journal of the American Veterinary Medical Association (JAVMA) — clinical case reports and studies on canine KCS therapies.
• Consult a board-certified veterinary ophthalmologist for personalized, evidence-based management for your Maltese.